Vimarsana
Biggest News Aggregation in the World

Page 3 - Exact Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exact Sciences Today - Breaking & Trending Today

7 Best Mid-Cap Healthcare Stocks To Buy Now - Vimarsana News

7 Best Mid-Cap Healthcare Stocks To Buy Now

The healthcare industry is considered to be a fairly defensive sector due to its need.

Exact Sciences to Participate in June Investor Conferences - Vimarsana News

Exact Sciences to Participate in June Investor Conferences

28.05.2024 - Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. William Blair ...

Founders can follow different strategies to success - Vimarsana News

Founders can follow different strategies to success

If there’s a common trait among effective entrepreneurs, it’s their tendency to follow unique paths to success.

Exact Sciences Co. (NASDAQ:EXAS) Position Decreased by 1492 Capital Management LLC - Vimarsana News

Exact Sciences Co. (NASDAQ:EXAS) Position Decreased by 1492 Capital Management LLC

1492 Capital Management LLC lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 84,154 shares of the medical research company’s stock after selling 362 shares during […]

Johnson Financial Group Inc. Has $392,000 Position in Exact Sciences Co. (NASDAQ:EXAS) - Vimarsana News

Johnson Financial Group Inc. Has $392,000 Position in Exact Sciences Co. (NASDAQ:EXAS)

Johnson Financial Group Inc. boosted its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 1,637.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,299 shares of the medical research company’s stock after buying an additional 4,994 shares during […]